Vycor Medical's Revolutionary ViewSite(TM) Neurosurgery Retraction Devices Adopted by the North Shore-LIJ Health System
April 14 2010 - 4:00AM
Marketwired
Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical
device company that designs, develops and markets next generation
neurosurgery retraction devices, today announced it has signed a
multi-year agreement with the North Shore-LIJ Health System
(www.northshorelij.com) for the use of its ViewSite
™ Brain Access System (VBAS) neurosurgery instruments.
Vycor's VBAS is already in use at two North Shore-LIJ hospitals,
with others in their network -- and scores of other hospitals
worldwide -- now considering the innovative neurosurgery retractors
designed to be minimally invasive, produce less tissue trauma and
maximize a surgeon's field of vision -- all resulting in speedier,
safer and more economical surgeries, a quicker patient discharge
and accelerated recovery.
"We continually strive to keep our network of hospitals
throughout Long Island, Queens and Staten Island at the forefront
of patient care with state-of-the-art instrumentation and
procedures," said Raj Narayan, MD, chairman of neurosurgery at
North Shore-LIJ. "Vycor's ViewSite Brain Access System is not only
highly cost effective, these progressive devices help us achieve
our on-going goal of enhancing neurosurgical procedure performance,
safety and results, thus adding value to our patients, staff and
hospitals at large."
"We are enthusiastic about the opportunity that this Agreement
presents for our company and ViewSite Brain Access System product
line," said Heather N. Vinas, president of Vycor Medical, Inc. "We
are a Long Island-based company and hold the entire North Shore-LIJ
Health System in high reverence."
"We're focused on bringing effective products to market that
allow the neurosurgical community to gain inroads," continues
Vinas. "We believe the ViewSite technology we have developed has
the potential of simplifying complicated brain surgeries. These
brain retractors allow neurosurgeons to have more precise access to
the surgical field, as well as increased binocular vision of
underlying tissue during brain surgery. Consequently, Vycor's new
surgical access system has the potential to reduce retraction
injuries and other complications that can occur when surgeons are
locating tumors."
About Vycor Medical, Inc. With corporate
headquarters in Bohemia, NY, Vycor Medical, Inc. (OTCBB: VYCO) is a
medical device company committed to making brain, spinal and other
surgical procedures safer and more effective. The company's
flagship, Patent Pending ViewSite™ Surgical Access Systems
represent an exciting new breed of retraction technology that holds
the potential for speedier, safer and more economical brain, spinal
and other surgeries and a quicker patient discharge. Vycor's
innovative medical instruments are designed to optimize
neurosurgical site access, reduce patient risk, accelerate
recovery, and add tangible value to the professional medical
community. Vycor is ISO 13485:2003 compliant, has FDA 510(K)
clearance for brain and spine surgeries, and CE marketing and HPB
licensing in Canada. Learn more online at www.vycormedical.com.
About North Shore-LIJ Health System As the
largest healthcare provider in the region, North Shore-LIJ offers
an unparalleled spectrum of high-quality services to meet all of
its patients' needs. The company's vast resources are matched by a
commitment to personalized health care -- whether treatment is
provided at one of its 14 hospitals, centers of progressive care,
long-term care facilities or through one of its home health
agencies. With more than 7,500 world-class physicians, 9,500 nurses
and other healthcare professionals, North Shore LIJ is dedicated to
providing compassionate care in a safe, comfortable environment
using the latest technology and treatment methods. Visit North
Shore-LIJ online at www.northshorelij.com.
Safe Harbor Statement Information in this
document constitute forward-looking statements or statements which
may be deemed or construed to be forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. The words "forecast", "anticipate", "estimate", "project",
"intend", "expect", "should", "believe", and similar expressions
are intended to identify forward-looking statements. These
forward-looking statements involve, and are subject to known and
unknown risks, uncertainties and other factors which could cause
Vycor Medical's actual results, performance (financial or
operating) or achievements to differ from the future results,
performance (financial or operating) or achievements expressed or
implied by such forward-looking statements. The risks,
uncertainties and other factors are more fully discussed in Vycor
Medical's filings with the U.S. Securities and Exchange Commission.
All forward-looking statements attributable to Vycor Medical herein
are expressly qualified in their entirety by the abovementioned
cautionary statement. Vycor Medical disclaims any obligation to
update forward-looking statements contained in this estimate,
except as may be required by law.
Press Contacts: Vycor Medical, Inc.: Jim Morham 951-833-8425
Email Contact 80 Orville Drive Suite 100 Bohemia, NY 11716
631.244.1435 www.vycormedical.com
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Jul 2023 to Jul 2024